First CE Mark for Patient Kits as Medical Devices Obtained by MedTrace
First CE Mark for Patient Kits as Medical Devices Obtained by MedTrace MedTrace recently gained its first CE mark for two of its medical devices less than 12 months after submitting the technical file. Obtaining the European CE mark demonstrates the company’s commitment and ability to successfully and in a short time bring a product […]
Shrinking the Manufacturing Footprint with PET Point-of-Care
Shrinking the Manufacturing Footprint with PET Point-of-Care “Today, most PET radiopharmaceuticals are produced at centralized locations and distributed. However, there are logistical limitations to this model and that is why it becomes increasingly interesting, and perhaps important, to consider point-of-care manufacturing.” – Jared Driskill, Senior Medical Advisor at MedTrace, in the January 2024 edition of […]
The First Scientific Article Based on a MedTrace-Sponsored Study Has Been Published
The First Scientific Article Based on a MedTrace-Sponsored Study Has Been Published MedTrace is proud to see the methodology paper “Rationale and design of the RAPID-WATER-FLOW trial: Radiolabeled perfusion to identify coronary artery disease using water to evaluate responses of myocardial FLOW” published in Journal of Nuclear Cardiology (2024) vol. 31. The article is authored, […]
MedTrace Has Activated Four New U.S. Sites, Adding Momentum and Excitement Around Its Phase III Clinical Trial
MedTrace Has Activated Four New U.S. Sites, Adding Momentum and Excitement Around Its Phase III Clinical Trial MedTrace, an innovator in PET diagnostic imaging, announces today that a total of five U.S. trial sites are up and running. Senior Director of Clinical Affairs, Emily Vandenbroucke, describes this development as a great boost to the momentum […]
MedTrace Appoints New Executive Management Team: Current CFO Ann Kristin Led Is the New CEO/CFO of MedTrace
MedTrace Appoints New Executive Management Team: Current CFO Ann Kristin Led Is the New CEO/CFO of MedTrace Pharmaceutical and medical device company MedTrace maintains a positive momentum. With Chief Financial Officer (CFO) Ann Kristin Led at the helm, the company recently announced a capital raise of 18 million euros. Today, the company presents a new […]
New Research Concludes That 15O-Water PET Can Be Used to Assess Blood Flow of the Right Ventricle
New Research Concludes That 15O-Water PET Can Be Used to Assess Blood Flow of the Right Ventricle At MedTrace we keep a close eye on all new scientific research related to 15O-water and we are happy to see yet again further indications of how relevant this tracer could be to cardiac diseases. The independent research […]
MedTrace Is Proud to Sponsor the Women in Nuclear Cardiology Event at ASNC2023
MedTrace is proud to sponsor The Women in Nuclear Cardiology Event at ASNC2023 MedTrace is showcasing its technology and Phase 3 Clinical Trial at ASNC2023, The American Society of Nuclear Cardiology’s annual conference, taking place in Toronto, Ontario, Canada from September 29 through October 1. This year, MedTrace is also sponsoring the Women in Nuclear Cardiology […]
MedTrace Receives an 18 Million Euro Investment for Completion of Its Phase 3 Trial
MedTrace Receives an 18 Million Euro Investment for Completion of its Phase 3 Trial The Danish pharmaceutical and medical device company MedTrace has just closed an investment round of 18.2 million euros, overperforming its target of raising 15 million. In a challenging capital market, the investors have reaffirmed their confidence in MedTrace’s goal of making […]
15O-Water Demonstrations at EANM’23: Experience the Daily Preparation and Setup of MedTrace’s 15O-Water Automated Manufacturing System
15O-Water Demonstrations at EANM’23: Experience the Daily Preparation and Setup of MedTrace’s 15O-Water Automated Manufacturing System 15O-Water Demonstrations at EANM’23: Experience the Daily Preparation and Setup of MedTrace’s 15O-Water Automated Manufacturing System When The Annual European Association of Nuclear Medicine Congress opens in Vienna on September 9, 2023, MedTrace is on the spot and ready […]
MedTrace Hosts 15O-Water Symposium for Nuclear Medicine Professionals
MedTrace hosts 15O-water symposium for nuclear medicine professionals 15O-water: Ready for the Future. Vol. 2. The symposium, sponsored by MedTrace, will take place on September 11, 2023, in Vienna. Guests can expect to hear from some of the world’s leading experts when they present new research and share their first-hand experiences with 15O-water. MedTrace is […]